In Silico and In Vitro Approach for Validating the Inhibition of Matrix Metalloproteinase-9 by Quercetin
暂无分享,去创建一个
[1] G. Gamov,et al. Binding of quercetin and curcumin to human serum albumin in aqueous dimethyl sulfoxide and in aqueous ethanol , 2022, Journal of Thermal Analysis and Calorimetry.
[2] Xue Tian,et al. Quercetin amelioratesAspergillus fumigatuskeratitis by inhibiting fungal growth, toll-like receptors and inflammatory cytokines. , 2021, International immunopharmacology.
[3] J. Caldeira,et al. Structure and Function of Human Matrix Metalloproteinases , 2020, Cells.
[4] M. Markoulli,et al. The relationship between tear film MMP-9 and meibomian gland changes during soft contact lens wear. , 2020, Contact lens & anterior eye : the journal of the British Contact Lens Association.
[5] Taher K Eleiwa,et al. Role of Matrix Metalloproteinase 9 in Ocular Surface Disorders. , 2020, Eye & contact lens.
[6] S. Singh,et al. Enhancing the potential preclinical and clinical benefits of quercetin through novel drug delivery systems. , 2019, Drug discovery today.
[7] M. Marra,et al. Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans , 2019, Nutrients.
[8] Yuan-Lu Cui,et al. Antioxidant activities of quercetin and its complexes 2 for medicinal application 3 , 2019 .
[9] A. Riva,et al. Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin , 2018, European Journal of Drug Metabolism and Pharmacokinetics.
[10] A. Riva,et al. Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin , 2018, European Journal of Drug Metabolism and Pharmacokinetics.
[11] C. Schaumburg,et al. Topical Quercetin and Resveratrol Protect the Ocular Surface in Experimental Dry Eye Disease , 2018, Ocular immunology and inflammation.
[12] A. Galor,et al. The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye. , 2016, The ocular surface.
[13] A. L. Muccillo-Baisch,et al. Anti-inflammatory Effect and Toxicology Analysis of Oral Delivery Quercetin Nanosized Emulsion in Rats , 2016, Pharmaceutical Research.
[14] John J. Irwin,et al. ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..
[15] J. Lee,et al. Effects of Quercetin in a Mouse Model of Experimental Dry Eye , 2015, Cornea.
[16] R. Beuerman,et al. Elevated expression of matrix metalloproteinase-9 and inflammatory cytokines in keratoconus patients is inhibited by cyclosporine A. , 2015, Investigative ophthalmology & visual science.
[17] N. Russo,et al. Understanding zinc(II) chelation with quercetin and luteolin: a combined NMR and theoretical study. , 2015, The journal of physical chemistry. B.
[18] C. O’Sullivan,et al. Zinc ionophore activity of quercetin and epigallocatechin-gallate: from Hepa 1-6 cells to a liposome model. , 2014, Journal of agricultural and food chemistry.
[19] C. Ren,et al. Intakes of total and individual flavonoids by US adults , 2014, International journal of food sciences and nutrition.
[20] Michael E. Hall,et al. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease. , 2013, Physiology.
[21] Nitin Patel,et al. Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation. , 2012, The American journal of pathology.
[22] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[23] M. Martí,et al. Inhibitory effect of quercetin on matrix metalloproteinase 9 activity molecular mechanism and structure-activity relationship of the flavonoid-enzyme interaction. , 2010, European journal of pharmacology.
[24] Seth M. Cohen,et al. Bidentate Zinc Chelators for α‐Carbonic Anhydrases that Produce a Trigonal Bipyramidal Coordination Geometry , 2010, ChemMedChem.
[25] M. Willcox,et al. Are Proteinases the Reason for Keratoconus? , 2010, Current eye research.
[26] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[27] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[28] J. Shoji,et al. Upregulation of Matrix Metalloproteinase in Tear Fluid of Patients with Recurrent Corneal Erosion , 2007, Japanese Journal of Ophthalmology.
[29] A. Solomon,et al. Regulation of MMP-9 production by human corneal epithelial cells. , 2001, Experimental eye research.
[30] A. Solomon,et al. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. , 2001, American journal of ophthalmology.
[31] A. Lampen,et al. Safety Aspects of the Use of Quercetin as a Dietary Supplement , 2018, Molecular nutrition & food research.
[32] Arthur J Olson,et al. Small-molecule library screening by docking with PyRx. , 2015, Methods in molecular biology.
[33] M. Fini,et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. , 2005, The American journal of pathology.
[34] K. Jeong,et al. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-κB pathway in lipopolysaccharide-stimulated macrophage , 2004, Molecular and Cellular Biochemistry.